1. Home
  2. EVEX vs SPRY Comparison

EVEX vs SPRY Comparison

Compare EVEX & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$3.91

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$10.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
SPRY
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVEX
SPRY
Price
$3.91
$10.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$6.88
$35.00
AVG Volume (30 Days)
990.8K
1.8M
Earning Date
03-10-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$142,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$126.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5459.66
52 Week Low
$2.83
$6.66
52 Week High
$7.70
$18.90

Technical Indicators

Market Signals
Indicator
EVEX
SPRY
Relative Strength Index (RSI) 34.85 44.00
Support Level $4.07 $10.01
Resistance Level $4.26 $10.79
Average True Range (ATR) 0.23 0.68
MACD -0.06 -0.16
Stochastic Oscillator 5.49 7.25

Price Performance

Historical Comparison
EVEX
SPRY

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: